Company / Working Capital per Share
Inhibrx Biosciences, Inc. Working Capital per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$6.84
FY2025
5-year range
$2.53 / $20.29
FY2023-FY2025
Trend
+170.8%
vs FY2024
Sector context
#79 of 210
Health Care
What the data says
At $6.84, Inhibrx Biosciences, Inc.'s working capital per share ranks #79 of 210 in the Health Care sector. Declined from $20.29 to $6.84 over the past 2 years.
Based on SEC 10-K filings.
6.84 in FY2025.
Declined from $20.29 to $6.84 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#79 of 210 in Health CareTop 38% of 210This company $6.84 Sector average $146.86
▼
-95.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 170.8% year-over-year.
- Ranks #79 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.84 | +170.8% |
| FY2024 | $2.53 | -87.5% |
| FY2023 | $20.29 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026